Application 065275
- Type
- ANDA
- Sponsor
- WEST-WARD PHARMS INT
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | IDARUBICIN HYDROCHLORIDE | IDARUBICIN HYDROCHLORIDE | INJECTABLE;INJECTION | 1MG/ML | No | No |
| 002 | IDARUBICIN HYDROCHLORIDE | IDARUBICIN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 10MG/10ML (1MG/ML) | No | No |
| 003 | IDARUBICIN HYDROCHLORIDE | IDARUBICIN HYDROCHLORIDE | SOLUTION;INTRAVENOUS | 20MG/20ML (1MG/ML) | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A065275-001 | IDARUBICIN HYDROCHLORIDE | IDARUBICIN HYDROCHLORIDE | 5MG/5ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2006-12-14 | |
| A065275-002 | IDARUBICIN HYDROCHLORIDE | IDARUBICIN HYDROCHLORIDE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2006-12-14 | |
| A065275-003 | IDARUBICIN HYDROCHLORIDE | IDARUBICIN HYDROCHLORIDE | 20MG/20ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2006-12-14 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A065275-001 | AP |
| A065275-002 | AP |
| A065275-003 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A065275-001 | IDARUBICIN HYDROCHLORIDE | 5MG/5ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2006-12-14 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A065275-002 | IDARUBICIN HYDROCHLORIDE | 10MG/10ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2006-12-14 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A065275-003 | IDARUBICIN HYDROCHLORIDE | 20MG/20ML (1MG/ML) | SOLUTION / INTRAVENOUS | AP | 2006-12-14 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A065275-001 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A065275-002 | AP | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A065275-003 | AP | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Idarubicin Hydrochloride | IDARUBICIN HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 7c20b574-285b-49eb-a98e-6752e4bb481d | 2025-01-07 | Boxed warning, Warnings, Adverse reactions | 065275 ANDA065275 0143-9307 0143-9308 0143-9306 |
| Idarubicin Hydrochloride | IDARUBICIN HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | b9b337d5-50f7-4ea9-9df4-72c86e4c0b91 | 2023-04-19 | Boxed warning, Warnings, Adverse reactions | 065275 ANDA065275 0143-9219 0143-9218 0143-9217 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0143-9217 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0143-9217 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9218 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0143-9218 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9219 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0143-9219 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9306 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0143-9306 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9307 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0143-9307 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | ANDA | Current |
| 0143-9308 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | West-Ward Pharmaceuticals Corp | ANDA | Current |
| 0143-9308 | Idarubicin Hydrochloride | Idarubicin Hydrochloride | Hikma Pharmaceuticals USA Inc. | ANDA | Current |